A unique integrated strategy and corporate and investment banking solution for global and emerging life science and healthcare companies.

The DNB//Back Bay Healthcare Partnership provides essential strategic and financial support to healthcare companies. We have a unique position bridging the Nordic and U.S. markets. Together, we provide a 360-degree understanding of healthcare corporate development, from chemistry to commercialization and raising capital to M&A as companies move through their lifecycle.

ABOUT THE PARTNERSHIP

The DNB//Back Bay Partnership was formalized in 2023 to provide healthcare companies with strategic guidance, M&A and partnering support and execution and capabilities in global capital markets and investment and commercial banking.

DNB, headquartered in Oslo, Norway, and Back Bay Life Science Advisors, headquartered in Boston, Massachusetts, are recognized leaders in banking and global life science development. Together, DNB and Back Bay Life Science Advisors offer unique support to companies along the full continuum of life science and healthcare development.

The DNB // Back Bay Partnership is comprised of dedicated multidisciplinary teams of healthcare experts and corporate and investment bankers who understand the complete picture of asset and company development.

Our combined expertise in healthcare and banking spans more than 110 years and 1,000 successful projects and transactions.

Learn more about the Partnership, subscribe for market insights, request an overview of our capabilities or connect with our advisors.

Analyst Reports

DNB//Back Bay publishes industry reports on the healthcare sector. Reports are authored by Back Bay Life Science Advisors’ experts on global life science development and DNB’s senior equity analysts.

Read our latest: 

Subscribe to our healthcare reports >>

 

Nordic-American Healthcare Conference 2025

The Leading US-Nordic Healthcare Public Equity Investor Conference Will Take Place March 26-27, 2025 in New York City.

Dates have been announced for the 9th annual NAHC. Hosted by DNB//Back Bay with Nasdaq Nordic, Innovation Norway and Business Sweden, this pre-eminent US-based Nordic healthcare equity investor event will convene in New York City on March 26–27, 2025, bringing together industry leaders, investors and innovators from across the global healthcare sector. LEARN MORE AND REQUEST A SEAT

STAY CONNECTED!

HEALTHCARE MARKETS UPDATE
NEWS & EVENTS

Learn more about the DNB//Back Bay Partnership and subscribe to our weekly market overview for healthcare IPOs, licensing, venture, M&A, follow-on, and PIPE/RDO activity.

MEET THE TEAM

Nasdaq welcomed the DNB//Back Bay Partnership with a tribute on the Nasdaq Tower, May 2023, New York City.

  • DNB is Norway’s largest financial institution and leading corporate and investment bank, with international expertise in corporate banking and public capital markets across selected industry sectors, specializing in arranging financing for healthcare companies globally.

    DNB has been established in North America since 1975, with a full-service branch in New York that serves corporate customers in the bank’s strategic business areas. A full range of wholesale investment banking services is provided by DNB Markets, Inc., a U.S. registered broker-dealer and wholly owned subsidiary of DNB Bank ASA in New York, established in 2003. Visit DNB Bank’s healthcare pages to learn more, here.

  • Back Bay Life Science Advisors (Back Bay) provides life science strategy and investment banking guidance and execution to global life science companies and their investors. Back Bay’s integrated strategy and banking teams advise companies on all aspects of life science, healthcare technology and drug development, including planning an initial concept, product commercialization, franchise growth, licensing, partnering, M&A, divestiture and more.

    With a strong presence in Europe and the Nordic markets and a global reach, Back Bay has guided hundreds of healthcare companies through the complexities of commercial development and transactions. Every project and transaction is rooted in Back Bay’s deep expertise in life science, healthcare industry strategy and investment banking.